Celecoxib to Prevent Cancer in Patients With Barrett's Esophagus

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

July 31, 2000

Primary Completion Date

September 30, 2005

Study Completion Date

September 30, 2005

Conditions
Esophageal Cancer
Interventions
DRUG

celecoxib

Trial Locations (8)

10032

Herbert Irving Comprehensive Cancer Center, New York

44106

Ireland Cancer Center, Cleveland

55905

Mayo Clinic Cancer Center, Rochester

60141

Veterans Affairs Medical Center - Hines (Hines Junior VA Hospital), Hines

85723

Veterans Affairs Medical Center - Tucson, Tucson

97207

Veterans Affairs Medical Center - Portland, Portland

90095-1781

Jonsson Comprehensive Cancer Center, UCLA, Los Angeles

21231-2410

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

OTHER

NCT00005878 - Celecoxib to Prevent Cancer in Patients With Barrett's Esophagus | Biotech Hunter | Biotech Hunter